1.05
Schlusskurs vom Vortag:
$0.8915
Offen:
$0.9
24-Stunden-Volumen:
25.89M
Relative Volume:
2.97
Marktkapitalisierung:
$435.14M
Einnahmen:
$4.78B
Nettoeinkommen (Verlust:
$-284.68M
KGV:
-1.5217
EPS:
-0.69
Netto-Cashflow:
$-184.84M
1W Leistung:
+17.98%
1M Leistung:
-52.91%
6M Leistung:
-69.83%
1J Leistung:
-81.18%
Agilon Health Inc Stock (AGL) Company Profile
Firmenname
Agilon Health Inc
Sektor
Branche
Telefon
562-256-3800
Adresse
6210 E HWY 290, AUSTIN
Vergleichen Sie AGL mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
AGL
Agilon Health Inc
|
1.05 | 357.77M | 4.78B | -284.68M | -184.84M | -0.69 |
![]()
HCA
Hca Healthcare Inc
|
390.46 | 91.33B | 72.70B | 5.97B | 7.29B | 23.79 |
![]()
THC
Tenet Healthcare Corp
|
171.87 | 15.06B | 20.52B | 1.46B | 1.41B | 15.12 |
![]()
FMS
Fresenius Medical Care Ag Adr
|
24.84 | 14.20B | 20.92B | 666.06M | 1.85B | 1.1422 |
![]()
EHC
Encompass Health Corp
|
119.13 | 11.95B | 5.51B | 494.70M | 386.40M | 4.84 |
![]()
UHS
Universal Health Services Inc
|
178.51 | 11.15B | 16.08B | 1.20B | 1.06B | 17.82 |
Agilon Health Inc Stock (AGL) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-08-06 | Herabstufung | Citigroup | Buy → Neutral |
2025-04-25 | Hochstufung | Citigroup | Neutral → Buy |
2025-04-08 | Hochstufung | Bernstein | Mkt Perform → Outperform |
2025-01-10 | Hochstufung | Citigroup | Sell → Neutral |
2025-01-10 | Eingeleitet | Needham | Hold |
2024-12-16 | Eingeleitet | Macquarie | Neutral |
2024-12-11 | Eingeleitet | Bernstein | Mkt Perform |
2024-11-11 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
2024-11-08 | Herabstufung | William Blair | Outperform → Mkt Perform |
2024-10-30 | Herabstufung | Citigroup | Neutral → Sell |
2024-10-02 | Herabstufung | BofA Securities | Buy → Underperform |
2024-05-30 | Eingeleitet | Robert W. Baird | Neutral |
2024-04-22 | Eingeleitet | Citigroup | Neutral |
2024-03-06 | Eingeleitet | Barclays | Underweight |
2024-02-26 | Herabstufung | Jefferies | Buy → Hold |
2024-02-26 | Herabstufung | TD Cowen | Outperform → Market Perform |
2024-01-08 | Herabstufung | Leerink Partners | Outperform → Market Perform |
2024-01-08 | Herabstufung | Stifel | Buy → Hold |
2024-01-08 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
2024-01-05 | Herabstufung | JP Morgan | Overweight → Neutral |
2024-01-05 | Herabstufung | Truist | Buy → Hold |
2023-12-11 | Herabstufung | Goldman | Buy → Neutral |
2023-12-06 | Eingeleitet | JMP Securities | Mkt Outperform |
2023-11-21 | Herabstufung | Deutsche Bank | Buy → Hold |
2023-10-20 | Eingeleitet | The Benchmark Company | Buy |
2023-06-13 | Eingeleitet | Evercore ISI | In-line |
2022-12-09 | Eingeleitet | Stifel | Buy |
2022-09-14 | Eingeleitet | RBC Capital Mkts | Outperform |
2022-09-12 | Eingeleitet | Goldman | Buy |
2022-09-07 | Fortgesetzt | Truist | Buy |
2022-06-24 | Eingeleitet | BTIG Research | Neutral |
2022-03-30 | Eingeleitet | Guggenheim | Buy |
2021-10-20 | Eingeleitet | Jefferies | Buy |
2021-09-27 | Eingeleitet | SVB Leerink | Outperform |
2021-09-10 | Eingeleitet | Cowen | Outperform |
2021-05-11 | Eingeleitet | William Blair | Outperform |
2021-05-10 | Eingeleitet | BofA Securities | Buy |
2021-05-10 | Eingeleitet | Deutsche Bank | Buy |
2021-05-10 | Eingeleitet | Goldman | Buy |
2021-05-10 | Eingeleitet | JP Morgan | Overweight |
2021-05-10 | Eingeleitet | Truist | Buy |
2021-05-10 | Eingeleitet | Wells Fargo | Overweight |
2021-05-10 | Eingeleitet | Wolfe Research | Outperform |
Alle ansehen
Agilon Health Inc Aktie (AGL) Neueste Nachrichten
Bronstein, Gewirtz & Grossman, LLC Encourages agilon health, inc. (AGL) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
How to build a custom watchlist for agilon health inc.2025 EndofYear Setup & Intraday High Probability Alerts - Newser
The Top 5 Analyst Questions From agilon health’s Q2 Earnings Call - Yahoo Finance
Earnings visualization tools for agilon health inc.July 2025 Pullbacks & Weekly High Return Opportunities - Newser
Visual trend scoring systems applied to agilon health inc.Free High Conviction Intraday Stock Signals - Newser
Can agilon health inc. recover in the next quarterFree Low Risk Picks for Daily Trading - Newser
Tandem Diabetes, iRhythm, agilon health, Fortrea, and 10x Genomics Shares Skyrocket and Plummet, What You Need To Know - TradingView
Why agilon health inc. stock attracts strong analyst attentionDay Trading Setup Forecast with Trend Model - Newser
Agilon Health shares fall 2.32% premarket after CEO's resignation and securities fraud investigations. - AInvest
Agilon Health, Inc. (NYSE:AGL) Shares Purchased by XTX Topco Ltd - Defense World
Is a relief rally coming for agilon health inc. holdersShort-Term Profit Alert With Entry Forecast - Newser
Agilon Health's Leadership Crisis and Earnings Withdrawal: A Wake-Up Call for Investors - AInvest
Agilon Health Under Investigation for Securities Fraud Violations - AInvest
agilon health, inc. Investigated for Securities Fraud ViolationsContact the DJS Law Group to Discuss Your Rights - Benzinga
AGILON ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire
AGILON ALERT: Bragar Eagel & Squire, P.C. is Investigating Agilon Health, Inc. on Behalf of Agilon Stockholders and Encourages Investors to Contact the Firm - GlobeNewswire Inc.
agilon health, inc. (AGL) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
A Closer Look at Agilon Health Inc (AGL) Stock Gains - investchronicle.com
Fibonacci Levels Suggest Recovery for agilon health inc.Capital Preserving Trade Plan Templates Shared - beatles.ru
Published on: 2025-08-11 04:07:55 - Newser
Using AI based signals to follow agilon health inc.Weekly Portfolio Update with ROI Focus - Newser
agilon health, inc. (AGL) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Should you wait for a breakout in agilon health inc.Intraday Strategy with Real Time Monitoring - Newser
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of agilon health, Inc. - GlobeNewswire Inc.
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against agilon health, inc. (AGL) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
Barclays Lowers Agilon Health (NYSE:AGL) Price Target to $1.50 - Defense World
William Blair Decreases Earnings Estimates for Agilon Health - Defense World
Agilon Health, Inc. (NYSE:AGL) Q2 2025 Earnings Call Transcript - Insider Monkey
agilon health, inc. (NYSE:AGL) Just Reported Earnings, And Analysts Cut Their Target Price - Yahoo Finance
agilon health CEO steps down; interim lead appointed - MSN
Agilon Health, Inc. (NYSE:AGL) Given Consensus Rating of “Hold” by Analysts - Defense World
Agilon Health’s Earnings Call: Challenges and Optimism - TipRanks
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of agilon health, Inc.AGL - PR Newswire
Agilon Health Investors Should Contact Block & Leviton to Find Out How They Might Recover Money Through the Firm's Investigation - TradingView
Agilon Health CEO Resignation and Earnings Guidance Suspension - MSN
Agilon Health: Benchmark Maintains Buy Rating with $1.5 PT from $4 - AInvest
agilon health Second Quarter 2025 Earnings: Misses Expectations - simplywall.st
Agilon Health (AGL) Reports Q2 Loss, Misses Revenue Estimates - MSN
Citigroup Downgrades agilon health to Neutral From Buy, Adjusts Price Target to $1 From $3 - MarketScreener
Citigroup Downgrades Agilon Health to Neutral From Buy, Adjusts Price Target to $1 From $3 - 富途牛牛
agilon health, inc. Securities Lawsuit Investigation - Claim Depot
Agilon Health (NYSE:AGL) Sets New 1-Year Low Following Weak Earnings - Defense World
Agilon Health Reports Q2 2025 Results Amid Leadership Change - TipRanks
Agilon Health's Q2 2025: Key Contradictions in Growth Strategy, Risk Assessment, and Cost Management - AInvest
agilon health, inc. 2025 Q2ResultsEarnings Call Presentation (NYSE:AGL) - Seeking Alpha
Agilon Health (AGL): Navigating Near-Term Turbulence for Long-Term Value Realization - AInvest
Agilon Health downgraded to Neutral from Buy at Citi - TipRanks
Capital World Investors Has $920.77 Million Stake in Agilon Health, Inc. (NYSE:AGL) - 富途牛牛
Agilon Health Inc (AGL) Q2 2025 Earnings Call Highlights: Strategic Initiatives and Challenges ... By GuruFocus - Investing.com Canada
agilon health inc reports results for the quarter ended June 30Earnings Summary - TradingView
Agilon Health (AGL.N) Suffers Unprecedented Intraday Drop—What's Behind the Crash? - AInvest
Finanzdaten der Agilon Health Inc-Aktie (AGL)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):